Clinical Trials

Status
Published

803 Results

Active Filters

Closed
Phase
III
Accrual
100%
Published
SWOG Clinical Trial Number
S1202

A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast Cancer

Status Notes
This protocol will be permanently closed to accrual effective 10/1/15.
Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Activated
05-15-2013
Closed
10-01-2015
ClinicalTrials.gov Registry Number
NCT01598298
Closed
Phase
Published
Closed
Phase
II
Accrual
100%
Published
SWOG Clinical Trial Number
S1115

Randomized Phase II Clinical Trial of AZD6244 Hydrogen Sulfate (NSC-748727) and MK-2206 (NSC-749607) vs. mFOLFOX in Patients with Metastatic Pancreatic Cancer after Prior Chemotherapy

Research Committee(s)
Gastrointestinal Cancer
Activated
08-15-2012
Closed
05-15-2014
ClinicalTrials.gov Registry Number
NCT01658943
Closed
Phase
Accrual
100%
Published
Closed
Phase
III
Accrual
100%
Published
SWOG Clinical Trial Number
S0927

Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer, Phase III

Research Committee(s)
Symptom Control and Quality of Life
Breast Cancer
Activated
02-01-2012
Closed
02-01-2013
ClinicalTrials.gov Registry Number
NCT01385137
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S1119

Gastric Cancer and Helicobacter Pylori Infection in Lima, Peru: The Role of Water Contamination

Research Committee(s)
Prevention
Activated
12-02-2011
Closed
08-05-2013
ClinicalTrials.gov Registry Number
NCT01512875
Closed
Phase
II
Published
SWOG Clinical Trial Number
CTSU/E2607

A Phase II Trial of Dasatinib in KIT-Positive Patients with Unresectable Locally Advanced or Stage IV Mucosal, Acral and Vulvovaginal Melanomas

Status Notes
This study will permanently close to accrual effective 12/29/15.
Research Committee(s)
Melanoma
Activated
12-01-2011
Closed
Phase
II
Accrual
100%
Published
SWOG Clinical Trial Number
S1108

Phase II Trial of the Aurora Kinase A Inhibitor, MLN8237, in Peripheral T-Cell Non-Hodgkin Lymphoma

Research Committee(s)
Lymphoma
Activated
10-28-2011
Closed
06-06-2013
Closed
Phase
II
Accrual
98%
Published
SWOG Clinical Trial Number
S1014

Abiraterone Acetate Treatment for Prostate Cancer Patients with a PSA of More Than Four Following Initial Androgen Deprivation Therapy, Phase II.

Research Committee(s)
Genitourinary Cancer
Activated
08-09-2011
Closed
08-01-2013
ClinicalTrials.gov Registry Number
NCT01309672
Closed
Phase
II
Accrual
100%
Published
SWOG Clinical Trial Number
S1005

A Phase II Study of MK-2206 (NSC-749607) as Second Line Therapy for Advanced Gastric and Gastroesophageal Junction Cancer

Research Committee(s)
Gastrointestinal Cancer
Activated
01-01-2011
Closed
05-01-2013
Closed
Phase
II
Accrual
100%
Published
SWOG Clinical Trial Number
S0925

A Randomized Phase II Study of Androgen Deprivation Combined with IMC-A12 Versus Androgen Deprivation Alone for Patients with New Hormone-Sensitive Metastatic Prostate Cancer

Research Committee(s)
Genitourinary Cancer
Activated
12-15-2010
Closed
12-01-2012
ClinicalTrials.gov Registry Number
NCT01120236
Closed
Phase
I-II
Accrual
100%
Published
SWOG Clinical Trial Number
S0806

A Phase I/II Trial of Vorinostat (SAHA) (NSC-701852) in Combination with Rituximab-CHOP in Patients with Newly Diagnosed Advanced Stage Diffuse Large B-Cell Lymphoma (DLBCL)

Research Committee(s)
Lymphoma
Activated
11-15-2010
Closed
10-01-2013
ClinicalTrials.gov Registry Number
NCT00972478
Closed
Published
Closed
Phase
II
Accrual
45%
Published
SWOG Clinical Trial Number
S0933

Phase II Study of RO4929097 (NSC-749225) in Advanced Melanoma

Research Committee(s)
Melanoma
Activated
10-28-2010
Closed
11-15-2011
ClinicalTrials.gov Registry Number
NCT01120275
Closed
Published
SWOG Clinical Trial Number
CTSU/NCIC MA.32

Phase III Randomized Trial of Metformin versus Placebo on Recurrence and Survival in Early Stage Breast Cancer

Research Committee(s)
Breast Cancer
Activated
09-15-2010
Closed
01-22-2013
Closed
Phase
II
Accrual
100%
Published
Closed
Phase
II
Accrual
73%
Published
SWOG Clinical Trial Number
S0941

Phase II Study of Sorafenib (NSC-724772) and Erlotinib (NSC-718781) in Patients with Advanced Gallbladder Carcinoma or Cholangiocarcinoma

Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-2010
Closed
09-15-2011
ClinicalTrials.gov Registry Number
NCT01093222